Diabetes drug linked to increased risk of bladder cancer

The results show that more than two years daily exposure to pioglitazone doubles the risk of bladder cancer. However, the authors stress that, in absolute terms, the risks are low – up to 137 extra cases per 100,000 person years.

Read more

Comments are closed.